Pharmexcil urges balance between compliance and commerce to safeguard India’s export momentum and ‘Pharmacy of the World’ status Read more
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Read more
AstraZeneca India gets CDSCO approval for additional indication for Osimertinib in unresectable EGFR-mutated lung cancer Read more
AstraZeneca’s Trastuzumab deruxtecan therapy receives CDSCO nod to manage HER2- low & ultra-low breast cancer in India Read more
Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes Read more